Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 8/20 | 0.52 |
| ▸ | RARG | P13631 | 8/20 | 0.52 |
| ▸ | RARA | P10276 | 7/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | CYP26A1 | O43174 | 3/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | VDR | P11473 | 4/20 | 0.43 |
| ▸ | RXRA | P19793 | 1/20 | 0.41 |
| ▸ | RXRB | P28702 | 1/20 | 0.41 |
| ▸ | RXRG | P48443 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4669351 | 1.00 | RARB (0.52) | RARBRARGRARACYP3A4CYP26A1 | |
| SCHEMBL4666486 | 0.94 | RARB (0.50) | RARBRARGRARACYP3A4CYP26A1 | |
| SCHEMBL4666454 | 0.94 | RARB (0.50) | RARBRARGRARACYP3A4CYP26A1 | |
| SCHEMBL6909571 | 0.91 | RARB (0.52) | RARBRARGRARACYP3A4CYP26A1 | |
| SCHEMBL10842924 | 0.90 | RARB (0.55) | RARBRARGRARACYP3A4CYP26A1 | |
| SCHEMBL10842927 | 0.90 | RARB (0.55) | RARBRARGRARACYP3A4CYP26A1 | |
| SCHEMBL10843882 | 0.89 | RARA (0.50) | RARBRARGRARACYP3A4CYP26A1 | |
| SCHEMBL10843886 | 0.89 | RARA (0.50) | RARBRARGRARACYP3A4CYP26A1 | |
| SCHEMBL10847379 | 0.88 | RARB (0.49) | RARBRARGRARACYP3A4CYP26A1 | |
| SCHEMBL10847377 | 0.88 | RARB (0.49) | RARBRARGRARACYP3A4CYP26A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1935869-A1 | Retinoids for the treatment of emphysema | F. HOFFMANN-LA ROCHE AG (CH) | 2008-06-25 | — | — | EP | disclosed |
| EP-1324970-A2 | RETINOIDS FOR THE TREATMENT OF EMPHYSEMA | F. HOFFMANN-LA ROCHE AG (CH) | 2003-07-09 | — | — | EP | disclosed |
| WO-2002028810-A2 | RETINOIDS FOR THE TREATMENT OF EMPHYSEMA | F. HOFFMANN-LA ROCHE AG (CH) | 2002-04-11 | — | — | WO | disclosed |